CIK 0001799191 · Accelerated filer<br>Smaller reporting company
Starling Oncology, Inc.
Sign in to watch- Tickers
- STLN DFPH
- Exchange
- Nasdaq, OTC
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 843562323
- Phone
- 562-735-3226
- Business address
- 18000 STUDEBAKER RD, SUITE 800, CERRITOS, CA, 90703
- Former names
- Oncology Institute, Inc., DFP HEALTHCARE ACQUISITIONS CORP.
Securities
- STLN Common Stock Nasdaq
- STLNW Warrant Nasdaq
- DFPH Common stock OTC
- Open-market buys, last 90 days
- $176,273
- in 1 filing
- Open-market sales, last 90 days
- $13,322,043
- in 2 filings, $1.9M under 10b5-1 plans
Net −$13,145,770. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-26 | Hively Brad Director | Purchase | +45,280 | $1.04 | $47K | 712,033 |
| 2025-03-26 | Hively Brad Director | Purchase · Common Warrant | +22,640 | $0.13 | $3K | 22,640 |
| 2025-03-26 | Virnich Daniel Chief Executive Officer | Purchase | +22,640 | $1.04 | $24K | 724,363 |
| 2025-03-26 | Virnich Daniel Chief Executive Officer | Purchase · Common Warrant | +11,320 | $0.13 | $1K | 11,320 |
| 2025-03-26 | Podnos Yale Chief Medical Officer | Purchase | +9,056 | $1.04 | $9K | 79,049 |
| 2025-03-26 | Podnos Yale Chief Medical Officer | Purchase · Common Warrant | +4,528 | $0.13 | $566 | 4,528 |
| 2025-03-26 | Pacala Mark L Director | Purchase | +90,562 | $1.04 | $94K | 224,971 |
| 2025-03-26 | Pacala Mark L Director | Purchase · Common Warrant | +42,281 | $0.13 | $5K | 42,281 |
| 2025-03-26 | Johnson Karen Marie Director | Purchase | +36,224 | $1.04 | $38K | 203,409 |
| 2025-03-26 | Johnson Karen Marie Director | Purchase · Common Warrant | +18,112 | $0.13 | $2K | 18,112 |
| 2025-03-26 | Hively Brad Director | Purchase | +9,056 | $1.04 | $9K | 675,809 |
| 2025-03-26 | Hively Brad Director | Purchase · Common Warrant | +4,528 | $0.13 | $566 | 4,528 |
| 2025-03-26 | Castle Jeremy Chief Operating Officer | Purchase | +9,056 | $1.04 | $9K | 90,386 |
| 2025-03-26 | Castle Jeremy Chief Operating Officer | Purchase · Common Warrant | +4,528 | $0.13 | $566 | 4,528 |
| 2025-03-26 | Carter Robert Ross Chief Financial Officer | Purchase | +9,056 | $1.04 | $9K | 39,407 |
| 2025-03-26 | Carter Robert Ross Chief Financial Officer | Purchase · Common Warrant | +4,528 | $0.13 | $566 | 4,528 |
| 2025-03-26 | BARASCH RICHARD A Director | Purchase | +1,358,448 | $1.04 | $1.4M | 1,775,641 |
| 2025-03-26 | BARASCH RICHARD A Director | Purchase · Common Warrant | +679,224 | $0.13 | $85K | 679,224 |
| 2025-03-26 | M33 Growth I L.P. Director | Grant or award | +2,716,898 | $1.04 | $2.8M | 16,420,701 |
| 2025-03-26 | M33 Growth I L.P. Director | Grant or award · Warrant to Purchase Shares of Common Stock | +1,358,449 | $0.13 | $170K | 1,358,449 |
Page 7 of 8 · 157 trades